• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2025, Vol. 27 ›› Issue (6): 571-575.

• 临床医药 • 上一篇    下一篇

亚麻醉剂量艾司氯胺酮联合TPVB对胸腔镜肺癌根治术患者应激反应和术后疼痛的影响

殷颖, 张子洁, 彭生*   

  1. 上海中医药大学附属龙华医院麻醉科,上海 201316
  • 收稿日期:2024-12-23 修回日期:2025-04-11 接受日期:2025-08-02 出版日期:2025-06-28 发布日期:2025-08-06
  • 基金资助:
    上海市卫健委临床研究面上项目(202240159)

Effects of Sub-Anesthesia Dose of Esketamine Combined with TPVB on Stress Response and Pain After Thoracoscopic Radical Resection of Lung Cancer

YIN Ying, ZHANG Zijie, PENG Sheng*   

  1. Department of Anesthesiology Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
    Shanghai 201316, China
  • Received:2024-12-23 Revised:2025-04-11 Accepted:2025-08-02 Online:2025-06-28 Published:2025-08-06

摘要:

目的:探究亚麻醉剂量艾司氯胺酮联合胸椎旁神经阻滞(TPVB)对胸腔镜肺癌根治术患者应激反应和术后疼痛的影响。方法:根据随机数字表法,将90例胸腔镜肺癌根治术患者分为试验组(亚麻醉剂量艾司氯胺酮联合TPVB联合全麻)和对照组(TPVB联合全麻),每组各45例。对比两组患者围术期情况、应激指标、术后疼痛、镇痛效果及不良反应发生情况。结果:与术前比较,两组患者术后3 d时血清血清皮质醇(Cor)、去甲肾上腺素(NE)和β-内啡肽(β-EP)水平均升高(P<0.05),试验组术后3 d时血清CorNEβ-EP水平低于对照组(P<0.05);试验组术后6122448 h静息和活动疼痛视觉模拟评分(VAS)低于对照组(P<0.05);试验组神经病理性疼痛发生率为6.67%3/45例),低于对照组的22.22%10/45例)(P<0.05)。试验组首次按压自控镇痛泵(PCIA)的时间晚于对照组,PCIA按压次数和24 hPCIA中舒芬太尼用量少于对照组(P<0.05)。两组麻醉相关不良反应发生率比较,差异无统计学意义(P>0.05)。结论:亚麻醉剂量艾司氯胺酮联合TPVB可有效减轻胸腔镜肺癌根治术患者应激反应和术后疼痛,降低神经病理性疼痛的发生率,且不额外增加不良反应。

  

关键词: 艾司氯胺酮, 胸椎旁神经阻滞, 亚麻醉剂量, 胸腔镜, 肺癌

Abstract:

Objective: To explore the effects of sub-anesthesia dose of esketamine combined with thoracic paravertebral block TPVB on stress response and pain after thoracoscopic radical resection of lung cancer.Methods: According to random number table method 90 patients undergoing thoracoscopic radical resection of lung cancer were divided into control group TPVB general anesthesia and experimental group sub-anesthesia dose of esketamine combined with TPVB general anesthesia), 45 cases in each group. The perioperative situations stress indexes postoperative pain analgesic effect and occurrence of adverse reactions in the two groups were compared.Results: At the 3 d after surgery levels of serum cortisol Cor), norepinephrine NE and β-endorphin β-EP increased in both groups P<0.05), and were lower in experimental group than those in the control group P<0.05. At the 6 12 24 and 48 h after surgery scores of visual analogue scale VAS for path under rest and motor states were lower in the experimental group than thne in the control group P<0.05. The incidence of neuropathic pain was lower in the experimental group than that in the control group 6.67% 3 cases/45 casesvs. 22.22% 10 cases/45 cases), P<0.05. The first compression time of patient controlled intravenous analgesia PCIA was later in the experimental group than that in the control group compression frequency of PCIA and sufentanil dosage within 24h after PCIA were lower in the experimental group P<0.05. The difference in the incidence of anesthesia-related adverse reactions between the two groups was not statistically significant P>0.05.Conclusion: Sub-anesthesia dose of esketamine combined with TPVB can effectively relieve stress response and pain and reduce the incidence of neuropathic pain after thoracoscopic radical resection of lung cancer and does not increase adverse reactions additionally.


Key words:  , Esketamine , Thoracic paravertebral block , Sub-anesthesia dose , Thoracoscope , Lung cancer

中图分类号: